The launch follows the introduction of vitaMedMD One Rx earlier this month and vitaMedMD Plus Rx last month, said the company.
vitaMedMD RediChew Rx contains folic acid and the patent-protected fourth generation folate, Quatrefolic, with a potential to further reduce the impact of folic acid related deficiencies such as spina bifida and anencephaly.
TherapeuticsMD vice president of Marketing Jason Spitz said vitaMedMD RediChew Rx provides an option for pregnant women who have difficulty swallowing tablets or capsules, or where nausea or morning sickness make taking tablets or capsules difficult.
"vitaMedMD RediChew Rx is also a suitable daily multivitamin choice for all women of childbearing age, as it provides the folic acid recommended by the U.S. Public Health Service, CDC, and the March of Dimes," Spitz said.
"With the addition of Quatrefolic, vitaMedMD prescription prenatals provide a ‘body ready’ form of folate, which is especially important for women with MTHFR polymorphisms who may not be able to fully metabolize synthetic folic acid."
The newly launched vitamin, only available in the US, also contains vitamins B6 and B12, which may help relieve nausea and morning sickness.